Tamfinder market filing
Global
Jul 15, 2026
AI copilot for founder mental health
TAM // TOTAL ADDRESSABLE MARKET
SAM // SERVICEABLE ADDRESSABLE MARKET
SOM 3YR // SERVICEABLE OBTAINABLE MARKET
Real pain, real demand, but the math tops out well below venture scale without a B2B pivot that the current positioning forecloses
Your SAM is $42M and your honest 3-year SOM is $1.3M, those numbers are not a venture story, they are a lifestyle business with upside only if you find a distribution lever the evidence does not support yet. The single weakest link is pricing: at $9.99/month (the Lovon-comparable ceiling your market will bear), you need roughly 83,000 paying founders to hit $10M ARR, but the evidence shows only 12% of founders turn to anyone external for support when in crisis, which means your conversion funnel is fighting a behavioral wall, not just a competitive one. Lyra Health ($5.9B valuation, $235M revenue) and Spring Health ($3.3B) own the employer distribution channel that generates reimbursable, recurring revenue, your B2C founder-direct model competes in the segment the evidence explicitly describes as 'walking away' from venture capital.
Key risk
At $120/yr B2C pricing, you need 83,000 paying founders to reach $10M ARR.
TAM // TOTAL ADDRESSABLE MARKET
$1.4B
Top-down: Global AI in mental health software market (software segment = 75.78% of ~$1.8B total in 2025) = ~$1.4B.
SOM 3YR // SERVICEABLE OBTAINABLE MARKET
$1.3M
Year 1: SAM = $42M. A competent new entrant realistically captures 0.5% in Year 1 = $210K. Year 2: 1.
>Methodology
TAM, Top-Down Narrowing
Global AI in mental health market 2025 consensus midpoint across three sources: ($1.8B + $1.99B + $1.81B) / 3 = ~$1.87B. Apply software segment share of 75.78% (Toward Healthcare) because this is a software product, not hardware or clinical services: $1.87B × 0.7578 = $1.42B, rounded to $1.4B. No further geographic narrowing applied since target is global.
($1.8B + $1.99B + $1.81B) / 3 × 75.78% = $1.4B
TAM, Bottom-Up Cross-Check
150M global startups (Limelight Digital). Assume 10% have a founder who is (a) reachable digitally, (b) capable of paying for SaaS, (c) not already served by employer benefits = 15M potential users. Pricing anchor: $9.99/mo × 12 = $120/yr (Lovon comparable, the only founder-adjacent B2C AI mental health price point in evidence). 15M × $120 = $1.8B. Agrees with top-down within 1.3x; no conflict flag. Top-down used as TAM because 15M paying founders overstates conversion reality.
150M startups × 10% addressable × $120/yr = $1.8B (cross-check only)
SAM, Segment Narrowing
Founders are approximately 3% of the working-age population (150M startups proxy against ~5B working-age adults globally, GEM 2024 states 1-in-8 engaged in entrepreneurial activity but most are not startup founders seeking mental health SaaS). Apply 3% to TAM: $1.4B × 3% = $42M. This is a proxy assumption, no published founder-specific AI mental health TAM exists in the evidence. B2C/prosumer model assumed; employer-channel TAM (Lyra, Spring) explicitly excluded as unreachable given positioning.
$1.4B TAM × 3% founder segment = $42M SAM
SOM, 3-Year Capture
Year 1: 0.5% of SAM = $210K (~1,750 users at $120/yr). Year 2: 1.5% of SAM = $630K (~5,250 users). Year 3: 3% of SAM = $1.26M (~10,500 users). Share ramp is conservative given: (1) no funded competitors directly own this B2C founder wedge, giving marginal whitespace; (2) consumer mental health app retention is notoriously poor; (3) 56% of founders get no support (demand signal) but only 12% turn to external sources (behavioral conversion barrier). 3-year SOM capped at 3% of SAM based on headwind severity.
Yr1: $42M × 0.5% = $210K | Yr2: $42M × 1.5% = $630K | Yr3: $42M × 3% = $1.3M
Competitors // Threat map
| Name | Funding | Positioning | Threat |
|---|---|---|---|
| Lyra Health | $635M raised, $5.9B valuation (Series F 2022), $235M revenue (2024) | AI-powered mental health benefits distributed through employer channels; not founder-specific but owns the highest-paying B2B buyer | Medium-direct: does not target founders specifically, but if any employer adds 'founder wellness' as a benefit, Lyra captures it through existing contracts. Its scale makes any B2B pivot by this startup a non-starter. |
| Spring Health | $3.3B valuation (2026) | Behavioral health benefits for employers with AI-driven assessments, coaching, therapy, same employer-channel playbook as Lyra | Medium-direct: same logic as Lyra. Collectively, Lyra and Spring have locked the employer distribution lane that generates reimbursable recurring revenue. |
| Wysa | Undisclosed from evidence; NHS-selected | Hybrid AI + human therapy; NHS Talking Therapy integration; has already launched 'Wysa Copilot', directly competing product name and concept | High: Wysa has already shipped a product called 'Copilot' in mental health, has clinical credibility via NHS selection, and operates at both B2C and B2B layers. This is the most direct competitive overlap with the proposed idea. |
| Woebot Health | Not specified in evidence beyond being a funded startup | CBT-based AI conversation tool; structured sequencing of therapeutic exercises | Low-medium: general consumer positioning, not founder-specific; free tier competes on price and erodes willingness to pay for a premium founder-focused product. |
| Modern Health | $167.4M raised | Mental well-being platform targeting companies to reduce burnout and turnover, closest thematic overlap with 'founder burnout' framing | Medium: if Modern Health or a competitor decides to launch a founder-specific SKU, they have distribution, clinical credibility, and capital that a new entrant lacks. |
Sources
- 01AI in Mental Health Market Sizing, Toward Healthcare · TAM top-down baseline ($1.45B 2024, $1.8B 2025); software segment share 75.78%
- 02Global AI in Mental Health Market, InsightAce Analytic · TAM triangulation cross-check ($1.99B 2025)
- 03AI in Mental Health Market, Roots Analysis · TAM triangulation cross-check ($1.81B 2025)
- 04Startup Statistics, Limelight Digital · Customer count denominator: 150M global startups, 50M launched annually
- 05Entrepreneurship Statistics, Hostinger · 665M entrepreneurs globally (GEM 2024/2025); 1-in-8 working-age engagement rate
- 06Founder Mental Health 2025, Sifted · Demand validation: 54% burnout, 46% rate mental health bad/very bad, 75% anxiety; 56% receive no investor mental health support, 12% turn to investors
- 07Tech Founder Burnout Statistics 2025, Cerevity · Demand validation: 73% of tech founders report shadow burnout
- 08AI Therapy Apps Compared, Basic Medical Key · B2C pricing anchors: Lovon $9.99/mo or $59.99/yr; Woebot and Wysa free tiers; state-level AI misrepresentation laws
- 09Mental Health Tech in 2026, Value Add VC · Competitor data: Spring Health $3.3B valuation; funding decline from $5.5B peak to $1.4B (2024); D2C consumer wellness walking away from funding
- 10AI in Mental Health 2026, Research2Guidance · Headwind: clinical-infrastructure vs. Consumer-wellness funding split; D2C retention and pricing pressures
- 11Lyra Health Revenue & Funding, GetLatka · Competitor: Lyra Health $235M revenue, $635M raised, $5.9B valuation
- 12Wysa Copilot Announcement, Wysa Blog · Competitor: Wysa Copilot product (direct naming conflict), NHS selection, hybrid AI+human model
- 13Digital Mental Health Technologies & Regulation, Pharmaphorum · Headwind: EU AI Act high-risk classification for AI in medical devices, data governance requirements
- 14Promise and Policy Challenges of Digital Mental Health, Bipartisan Policy Center · Headwind: reimbursement gaps, slow CMS expansion, limited FDA-cleared tools
- 15Modern Health, Medical Startups · Competitor: Modern Health $167.4M funding, burnout/turnover positioning
More filings
Size another idea